SMART - is it practical in the United States? : Current Opinion in Pulmonary Medicine SMART -
is it practical in the United States? : Current Opinion in Pulmonary Medicine Log in or Register …

Severe asthma is a difficult-to-treat chronic airway inflammatory disease requiring systemic
corticosteroids to achieve asthma control. It has recently been shown that drugs targeting …

Background Little information is known about the health-related quality of life (HRQOL) and
the patient's preference values by the severity of asthma. We evaluated the HRQOL and …

Objective The study aimed to reach a consensus on the most relevant patient-reported
outcomes (PROs), the corresponding measures (PROMs), and measurement frequency …

Purpose Asthma is a major chronic disease of all ages, globally. Exacerbations are a
significant problem for asthmatic patients. Despite advances in asthma management and …

Abstract Background and Aim Benralizumab is a biologic add-on treatment for severe
eosinophilic asthma that can reduce the rate of asthma exacerbations, but data on the …

Topic importance Asthma is a common multifaceted respiratory disease with a major impact
on quality of life. Despite increased insights into mechanisms underlying various asthma …

Background Adherence barriers to asthma biologics may not be uniform across
administration settings for patients with moderate-to-severe asthma. Objective To examine …

Objective This study aimed to evaluate trends in polypharmacy prevalence among adults
with asthma in the United States. Methods Data from the 2001–2020 National Health and …

Introduction Asthma is a chronic condition with a high prevalence and cost of care among
children and adolescents. While previous research described the association of …